Table 2 The percentages of CKD related complications in the groups staged by eGFR and ACR levels
CKD G3a (n = 417) | P for trend (G3a) | CKD G3b (n = 685) | P for trend (G3b) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
A1a n = 39 | A1b n = 45 | A2 n = 118 | A3 n = 215 | A1a n = 43 | A1b n = 56 | A2 n = 226 | A3 n = 360 | P for trend (total) | |||
Hypertension | 32 (82.1%) | 36 (80.0%) | 101 (85.6%) | 167 (77.7%) | 0.37 | 35 (81.4%) | 43 (76.8%) | 187 (82.7%) | 293 (81.4%) | 0.78 | 0.87 |
Hyperlipidemia | 11 (28.2%) | 15 (33.3%) | 34 (28.8%) | 77 (35.8%) | 0.25 | 6 (14.0%) | 11 (19.6%) | 51 (22.6%) | 127 (35.3%) | <0.001 | 0.98 |
Hyperuricemia | 21 (53.9%) | 17 (37.8%) | 61 (51.7%) | 117 (54.4%) | 0.36 | 19 (44.2%) | 34 (60.7%) | 151 (66.8%) | 214 (59.4%) | 0.55 | 0.001 |
Anemia | 7 (18.0%) | 8 (17.8%) | 17 (14.4%) | 43 (20.0%) | 0.54 | 12 (27.9%) | 9 (16.1%) | 40 (17.7%) | 104 (28.9%) | 0.05 | 0.001 |
Metabolic Acidosis | 3 (7.7%) | 9 (20.0%) | 22 (18.6%) | 38 (17.7%) | 0.34 | 9 (20.9%) | 15 (26.8%) | 50 (22.1%) | 64 (17.8%) | 0.16 | 0.38 |
CKD-MBD | 30 (76.9%) | 33 (73.3%) | 95 (80.5%) | 168 (78.1%) | 0.71 | 31 (72.1%) | 49 (87.5%) | 181 (80.1%) | 291 (80.8%) | 0.63 | 0.26 |
CVD | 10 (25.6%) | 18 (40.0%) | 21 (17.8%) | 63 (29.3%) | 1 | 11 (25.6%) | 18 (32.1%) | 71 (31.4%) | 98 (27.2%) | 0.68 | 0.56 |
Quality of Life | 40.15 ± 18.69 | 38.41 ± 17.76 | 43.87 ± 18.52 | 42.18 ± 19.16 | 0.41 | 37.16 ± 16.27 | 42.68 ± 17.89 | 39.54 ± 19.42 | 38.98 ± 20.71 | 0.63 | 0.25 |